Publication
Neuroendocrine tumors; measures to improve treatment and supportive care
de Hosson, L. D., 2019, [Groningen]: Rijksuniversiteit Groningen. 157 p.Research output: Thesis › Thesis fully internal (DIV)

Documents
- Title and contents
Final publisher's version, 724 KB, PDF document
- Chapter 1
Final publisher's version, 643 KB, PDF document
- Chapter 2
Final publisher's version, 839 KB, PDF document
- Chapter 3a
Final publisher's version, 734 KB, PDF document
- Chapter 3b
Final publisher's version, 749 KB, PDF document
- Chapter 4
Final publisher's version, 724 KB, PDF document
- Chapter 5
Final publisher's version, 2.34 MB, PDF document
- Chapter 6
Final publisher's version, 2.1 MB, PDF document
- Chapter 7
Final publisher's version, 701 KB, PDF document
- Nederlandse samenvatting
Final publisher's version, 637 KB, PDF document
- Dankwoord
Final publisher's version, 625 KB, PDF document
- Complete thesis
Final publisher's version, 4.41 MB, PDF document
- Propositions
Final publisher's version, 269 KB, PDF document
Furthermore, we showed that lesions with high 18Fluorine-L-dihydroxyphenylalanine ([18F]FDOPA) uptake could be detected in patients with NET on the [18F]FDOPA PET scan. This suggests that [18F]FDOPA PET scans can support selection of lesions with substantially higher [18F]FDOPA uptake, and probably higher excretion of neuroendocrine amines, for local treatment.
Finally, we analyzed the NET immune microenvironment. We demonstrated that NETs lack pre-existing immunity. This can have impact on future trials investing immunotherapies in patients with NETs.
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution | |
Supervisors/Advisors |
|
Award date | 20-Feb-2019 |
Place of Publication | [Groningen] |
Publisher | |
Print ISBNs | 978-94-034-1443-0 |
Electronic ISBNs | 978-94-034-1442-3 |
Publication status | Published - 2019 |
Download statistics
ID: 75932802